nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefazolin—PON1—obesity	0.474	0.9	CbGaD
Cefazolin—SLC22A11—Cimetidine—obesity	0.123	0.503	CbGbCtD
Cefazolin—SLC22A8—Cimetidine—obesity	0.0717	0.293	CbGbCtD
Cefazolin—ALB—obesity	0.0528	0.1	CbGaD
Cefazolin—SLC22A6—Cimetidine—obesity	0.0499	0.204	CbGbCtD
Cefazolin—PON1—cardiovascular system—obesity	0.00305	0.159	CbGeAlD
Cefazolin—PON1—endocrine gland—obesity	0.00209	0.109	CbGeAlD
Cefazolin—PON1—liver—obesity	0.00189	0.0985	CbGeAlD
Cefazolin—TPMT—islet of Langerhans—obesity	0.00128	0.067	CbGeAlD
Cefazolin—ALB—gall bladder—obesity	0.00122	0.0634	CbGeAlD
Cefazolin—TPMT—adrenal cortex—obesity	0.00102	0.0531	CbGeAlD
Cefazolin—TPMT—pituitary gland—obesity	0.000822	0.0429	CbGeAlD
Cefazolin—TPMT—adipose tissue—obesity	0.000819	0.0427	CbGeAlD
Cefazolin—SLC22A11—digestive system—obesity	0.000815	0.0425	CbGeAlD
Cefazolin—Ceftriaxone—GLUL—obesity	0.000742	0.423	CrCbGaD
Cefazolin—TPMT—adrenal gland—obesity	0.000735	0.0383	CbGeAlD
Cefazolin—SLC22A11—endocrine gland—obesity	0.000673	0.0351	CbGeAlD
Cefazolin—TPMT—endocrine gland—obesity	0.000637	0.0332	CbGeAlD
Cefazolin—SLC22A11—liver—obesity	0.000607	0.0317	CbGeAlD
Cefazolin—TPMT—liver—obesity	0.000574	0.03	CbGeAlD
Cefazolin—Agitation—Phentermine—obesity	0.000568	0.00546	CcSEcCtD
Cefazolin—Mouth ulceration—Sibutramine—obesity	0.000565	0.00544	CcSEcCtD
Cefazolin—Thrombocytosis—Topiramate—obesity	0.000558	0.00537	CcSEcCtD
Cefazolin—Urticaria—Methamphetamine—obesity	0.000557	0.00536	CcSEcCtD
Cefazolin—Erythema multiforme—Cimetidine—obesity	0.000555	0.00534	CcSEcCtD
Cefazolin—Hypertonia—Sibutramine—obesity	0.000548	0.00527	CcSEcCtD
Cefazolin—Hyperkinesia—Sibutramine—obesity	0.000545	0.00525	CcSEcCtD
Cefazolin—Vaginal inflammation—Bupropion—obesity	0.000545	0.00524	CcSEcCtD
Cefazolin—Urticaria—Benzphetamine—obesity	0.000537	0.00517	CcSEcCtD
Cefazolin—Decreased appetite—Phendimetrazine—obesity	0.000536	0.00516	CcSEcCtD
Cefazolin—Confusional state—Phenylpropanolamine—obesity	0.000531	0.00511	CcSEcCtD
Cefazolin—Phlebitis—Sibutramine—obesity	0.000526	0.00507	CcSEcCtD
Cefazolin—Colitis—Bupropion—obesity	0.000523	0.00503	CcSEcCtD
Cefazolin—Hepatic function abnormal—Sibutramine—obesity	0.000519	0.005	CcSEcCtD
Cefazolin—Hypersensitivity—Methamphetamine—obesity	0.000517	0.00498	CcSEcCtD
Cefazolin—Vaginal infection—Bupropion—obesity	0.000514	0.00495	CcSEcCtD
Cefazolin—Flatulence—Cimetidine—obesity	0.000504	0.00485	CcSEcCtD
Cefazolin—Hypersensitivity—Benzphetamine—obesity	0.000498	0.0048	CcSEcCtD
Cefazolin—Agitation—Diethylpropion—obesity	0.000494	0.00475	CcSEcCtD
Cefazolin—Mouth ulceration—Bupropion—obesity	0.000492	0.00474	CcSEcCtD
Cefazolin—ABCC4—adipose tissue—obesity	0.000492	0.0257	CbGeAlD
Cefazolin—Hypotension—Phenylpropanolamine—obesity	0.000492	0.00474	CcSEcCtD
Cefazolin—Abdominal pain—Phendimetrazine—obesity	0.000487	0.00469	CcSEcCtD
Cefazolin—Leukopenia—Diethylpropion—obesity	0.000481	0.00463	CcSEcCtD
Cefazolin—Diarrhoea—Methamphetamine—obesity	0.00048	0.00462	CcSEcCtD
Cefazolin—Hypertonia—Bupropion—obesity	0.000477	0.0046	CcSEcCtD
Cefazolin—Hyperkinesia—Bupropion—obesity	0.000475	0.00457	CcSEcCtD
Cefazolin—Agitation—Cimetidine—obesity	0.00047	0.00452	CcSEcCtD
Cefazolin—Somnolence—Phenylpropanolamine—obesity	0.000468	0.00451	CcSEcCtD
Cefazolin—Convulsion—Diethylpropion—obesity	0.000465	0.00448	CcSEcCtD
Cefazolin—Dizziness—Methamphetamine—obesity	0.000464	0.00447	CcSEcCtD
Cefazolin—ABCC4—digestive system—obesity	0.000463	0.0242	CbGeAlD
Cefazolin—Diarrhoea—Benzphetamine—obesity	0.000463	0.00446	CcSEcCtD
Cefazolin—Phlebitis—Bupropion—obesity	0.000459	0.00442	CcSEcCtD
Cefazolin—Leukopenia—Cimetidine—obesity	0.000458	0.0044	CcSEcCtD
Cefazolin—ALB—adrenal gland—obesity	0.000456	0.0238	CbGeAlD
Cefazolin—Hepatic function abnormal—Bupropion—obesity	0.000452	0.00435	CcSEcCtD
Cefazolin—Dizziness—Benzphetamine—obesity	0.000447	0.00431	CcSEcCtD
Cefazolin—Dyspepsia—Phentermine—obesity	0.000444	0.00427	CcSEcCtD
Cefazolin—ABCC4—adrenal gland—obesity	0.000442	0.023	CbGeAlD
Cefazolin—Headache—Methamphetamine—obesity	0.00044	0.00423	CcSEcCtD
Cefazolin—Fatigue—Phentermine—obesity	0.000435	0.00418	CcSEcCtD
Cefazolin—Feeling abnormal—Phenylpropanolamine—obesity	0.000434	0.00418	CcSEcCtD
Cefazolin—Abdominal pain upper—Orlistat—obesity	0.000428	0.00412	CcSEcCtD
Cefazolin—Blood creatinine increased—Sibutramine—obesity	0.000425	0.00409	CcSEcCtD
Cefazolin—Headache—Benzphetamine—obesity	0.000424	0.00408	CcSEcCtD
Cefazolin—Diarrhoea—Phendimetrazine—obesity	0.000422	0.00406	CcSEcCtD
Cefazolin—Confusional state—Cimetidine—obesity	0.000421	0.00405	CcSEcCtD
Cefazolin—Anaphylactic shock—Cimetidine—obesity	0.000417	0.00402	CcSEcCtD
Cefazolin—Thrombocytopenia—Cimetidine—obesity	0.000408	0.00393	CcSEcCtD
Cefazolin—Aspartate aminotransferase increased—Sibutramine—obesity	0.000408	0.00393	CcSEcCtD
Cefazolin—Dizziness—Phendimetrazine—obesity	0.000408	0.00392	CcSEcCtD
Cefazolin—Nausea—Benzphetamine—obesity	0.000402	0.00387	CcSEcCtD
Cefazolin—Urticaria—Phentermine—obesity	0.0004	0.00385	CcSEcCtD
Cefazolin—Abdominal pain—Phentermine—obesity	0.000398	0.00384	CcSEcCtD
Cefazolin—Somnolence—Diethylpropion—obesity	0.00039	0.00375	CcSEcCtD
Cefazolin—Eosinophilia—Sibutramine—obesity	0.000388	0.00374	CcSEcCtD
Cefazolin—Hypersensitivity—Phenylpropanolamine—obesity	0.000388	0.00374	CcSEcCtD
Cefazolin—Headache—Phendimetrazine—obesity	0.000386	0.00372	CcSEcCtD
Cefazolin—Dyspepsia—Diethylpropion—obesity	0.000386	0.00372	CcSEcCtD
Cefazolin—ABCC4—endocrine gland—obesity	0.000383	0.02	CbGeAlD
Cefazolin—Somnolence—Cimetidine—obesity	0.000371	0.00357	CcSEcCtD
Cefazolin—Nausea—Phendimetrazine—obesity	0.000366	0.00353	CcSEcCtD
Cefazolin—Creatinine increased—Topiramate—obesity	0.000365	0.00351	CcSEcCtD
Cefazolin—Asthenia—Phentermine—obesity	0.000362	0.00348	CcSEcCtD
Cefazolin—Feeling abnormal—Diethylpropion—obesity	0.000361	0.00348	CcSEcCtD
Cefazolin—Abdominal pain upper—Bupropion—obesity	0.000361	0.00348	CcSEcCtD
Cefazolin—Fatigue—Cimetidine—obesity	0.00036	0.00346	CcSEcCtD
Cefazolin—ALB—liver—obesity	0.000357	0.0186	CbGeAlD
Cefazolin—Renal failure—Orlistat—obesity	0.000355	0.00342	CcSEcCtD
Cefazolin—Urticaria—Diethylpropion—obesity	0.000348	0.00335	CcSEcCtD
Cefazolin—Dizziness—Phenylpropanolamine—obesity	0.000348	0.00335	CcSEcCtD
Cefazolin—Vaginal inflammation—Topiramate—obesity	0.000347	0.00334	CcSEcCtD
Cefazolin—ABCC4—liver—obesity	0.000345	0.018	CbGeAlD
Cefazolin—Diarrhoea—Phentermine—obesity	0.000345	0.00332	CcSEcCtD
Cefazolin—Feeling abnormal—Cimetidine—obesity	0.000344	0.00331	CcSEcCtD
Cefazolin—Renal failure—Sibutramine—obesity	0.000344	0.00331	CcSEcCtD
Cefazolin—Stomatitis—Sibutramine—obesity	0.000341	0.00328	CcSEcCtD
Cefazolin—Vomiting—Phenylpropanolamine—obesity	0.000335	0.00322	CcSEcCtD
Cefazolin—Dizziness—Phentermine—obesity	0.000333	0.00321	CcSEcCtD
Cefazolin—Rash—Phenylpropanolamine—obesity	0.000332	0.0032	CcSEcCtD
Cefazolin—Dermatitis—Phenylpropanolamine—obesity	0.000332	0.00319	CcSEcCtD
Cefazolin—Candida infection—Topiramate—obesity	0.000331	0.00319	CcSEcCtD
Cefazolin—Body temperature increased—Cimetidine—obesity	0.00033	0.00317	CcSEcCtD
Cefazolin—Vaginal infection—Topiramate—obesity	0.000328	0.00315	CcSEcCtD
Cefazolin—Haemoglobin—Orlistat—obesity	0.000326	0.00314	CcSEcCtD
Cefazolin—Pancytopenia—Bupropion—obesity	0.000325	0.00312	CcSEcCtD
Cefazolin—Haemorrhage—Orlistat—obesity	0.000324	0.00312	CcSEcCtD
Cefazolin—Hepatitis—Orlistat—obesity	0.000324	0.00312	CcSEcCtD
Cefazolin—Vomiting—Phentermine—obesity	0.00032	0.00308	CcSEcCtD
Cefazolin—Rash—Phentermine—obesity	0.000318	0.00306	CcSEcCtD
Cefazolin—Dermatitis—Phentermine—obesity	0.000318	0.00306	CcSEcCtD
Cefazolin—Headache—Phentermine—obesity	0.000316	0.00304	CcSEcCtD
Cefazolin—Haemoglobin—Sibutramine—obesity	0.000315	0.00304	CcSEcCtD
Cefazolin—Haemorrhage—Sibutramine—obesity	0.000314	0.00302	CcSEcCtD
Cefazolin—Mouth ulceration—Topiramate—obesity	0.000314	0.00302	CcSEcCtD
Cefazolin—Nausea—Phenylpropanolamine—obesity	0.000313	0.00301	CcSEcCtD
Cefazolin—Hypersensitivity—Cimetidine—obesity	0.000307	0.00296	CcSEcCtD
Cefazolin—Hypertonia—Topiramate—obesity	0.000304	0.00293	CcSEcCtD
Cefazolin—Hyperkinesia—Topiramate—obesity	0.000303	0.00291	CcSEcCtD
Cefazolin—Stevens-Johnson syndrome—Bupropion—obesity	0.000302	0.00291	CcSEcCtD
Cefazolin—Diarrhoea—Diethylpropion—obesity	0.0003	0.00289	CcSEcCtD
Cefazolin—Nausea—Phentermine—obesity	0.000299	0.00288	CcSEcCtD
Cefazolin—Asthenia—Cimetidine—obesity	0.000299	0.00288	CcSEcCtD
Cefazolin—Stomatitis—Bupropion—obesity	0.000297	0.00286	CcSEcCtD
Cefazolin—Phlebitis—Topiramate—obesity	0.000292	0.00281	CcSEcCtD
Cefazolin—Dizziness—Diethylpropion—obesity	0.00029	0.00279	CcSEcCtD
Cefazolin—Diarrhoea—Cimetidine—obesity	0.000285	0.00275	CcSEcCtD
Cefazolin—Vomiting—Diethylpropion—obesity	0.000279	0.00268	CcSEcCtD
Cefazolin—Flatulence—Orlistat—obesity	0.000278	0.00268	CcSEcCtD
Cefazolin—Rash—Diethylpropion—obesity	0.000276	0.00266	CcSEcCtD
Cefazolin—Dermatitis—Diethylpropion—obesity	0.000276	0.00266	CcSEcCtD
Cefazolin—Dizziness—Cimetidine—obesity	0.000276	0.00266	CcSEcCtD
Cefazolin—Haemoglobin—Bupropion—obesity	0.000275	0.00265	CcSEcCtD
Cefazolin—Headache—Diethylpropion—obesity	0.000275	0.00264	CcSEcCtD
Cefazolin—Hepatitis—Bupropion—obesity	0.000274	0.00263	CcSEcCtD
Cefazolin—Haemorrhage—Bupropion—obesity	0.000274	0.00263	CcSEcCtD
Cefazolin—Flatulence—Sibutramine—obesity	0.000269	0.00259	CcSEcCtD
Cefazolin—Vomiting—Cimetidine—obesity	0.000265	0.00255	CcSEcCtD
Cefazolin—Rash—Cimetidine—obesity	0.000263	0.00253	CcSEcCtD
Cefazolin—Dermatitis—Cimetidine—obesity	0.000263	0.00253	CcSEcCtD
Cefazolin—Headache—Cimetidine—obesity	0.000261	0.00252	CcSEcCtD
Cefazolin—Nausea—Diethylpropion—obesity	0.00026	0.00251	CcSEcCtD
Cefazolin—Erythema multiforme—Bupropion—obesity	0.000259	0.00249	CcSEcCtD
Cefazolin—Anaemia—Sibutramine—obesity	0.000252	0.00243	CcSEcCtD
Cefazolin—Agitation—Sibutramine—obesity	0.000251	0.00242	CcSEcCtD
Cefazolin—Nausea—Cimetidine—obesity	0.000248	0.00239	CcSEcCtD
Cefazolin—Syncope—Sibutramine—obesity	0.000245	0.00236	CcSEcCtD
Cefazolin—Convulsion—Orlistat—obesity	0.000245	0.00235	CcSEcCtD
Cefazolin—Leukopenia—Sibutramine—obesity	0.000244	0.00235	CcSEcCtD
Cefazolin—Loss of consciousness—Sibutramine—obesity	0.00024	0.00231	CcSEcCtD
Cefazolin—Convulsion—Sibutramine—obesity	0.000237	0.00228	CcSEcCtD
Cefazolin—Blood creatinine increased—Topiramate—obesity	0.000236	0.00227	CcSEcCtD
Cefazolin—Flatulence—Bupropion—obesity	0.000235	0.00226	CcSEcCtD
Cefazolin—Anaphylactic shock—Orlistat—obesity	0.00023	0.00222	CcSEcCtD
Cefazolin—Abdominal pain upper—Topiramate—obesity	0.00023	0.00221	CcSEcCtD
Cefazolin—Aspartate aminotransferase increased—Topiramate—obesity	0.000227	0.00218	CcSEcCtD
Cefazolin—Toxic epidermal necrolysis—Topiramate—obesity	0.000227	0.00218	CcSEcCtD
Cefazolin—Confusional state—Sibutramine—obesity	0.000225	0.00216	CcSEcCtD
Cefazolin—Anaphylactic shock—Sibutramine—obesity	0.000223	0.00215	CcSEcCtD
Cefazolin—Anaemia—Bupropion—obesity	0.00022	0.00212	CcSEcCtD
Cefazolin—Shock—Sibutramine—obesity	0.000219	0.00211	CcSEcCtD
Cefazolin—Agitation—Bupropion—obesity	0.000219	0.00211	CcSEcCtD
Cefazolin—Thrombocytopenia—Sibutramine—obesity	0.000218	0.0021	CcSEcCtD
Cefazolin—Cefotetan—ALB—obesity	0.000217	0.124	CrCbGaD
Cefazolin—Eosinophilia—Topiramate—obesity	0.000216	0.00207	CcSEcCtD
Cefazolin—Syncope—Bupropion—obesity	0.000214	0.00206	CcSEcCtD
Cefazolin—Leukopenia—Bupropion—obesity	0.000213	0.00205	CcSEcCtD
Cefazolin—Anorexia—Sibutramine—obesity	0.000212	0.00205	CcSEcCtD
Cefazolin—Loss of consciousness—Bupropion—obesity	0.000209	0.00201	CcSEcCtD
Cefazolin—Hypotension—Sibutramine—obesity	0.000208	0.002	CcSEcCtD
Cefazolin—Pancytopenia—Topiramate—obesity	0.000207	0.00199	CcSEcCtD
Cefazolin—Convulsion—Bupropion—obesity	0.000206	0.00199	CcSEcCtD
Cefazolin—Neutropenia—Topiramate—obesity	0.000204	0.00196	CcSEcCtD
Cefazolin—Dyspepsia—Orlistat—obesity	0.000203	0.00195	CcSEcCtD
Cefazolin—Decreased appetite—Orlistat—obesity	0.0002	0.00193	CcSEcCtD
Cefazolin—Fatigue—Orlistat—obesity	0.000199	0.00191	CcSEcCtD
Cefazolin—Somnolence—Sibutramine—obesity	0.000198	0.00191	CcSEcCtD
Cefazolin—Pain—Orlistat—obesity	0.000197	0.0019	CcSEcCtD
Cefazolin—Dyspepsia—Sibutramine—obesity	0.000196	0.00189	CcSEcCtD
Cefazolin—Confusional state—Bupropion—obesity	0.000196	0.00189	CcSEcCtD
Cefazolin—Anaphylactic shock—Bupropion—obesity	0.000194	0.00187	CcSEcCtD
Cefazolin—Decreased appetite—Sibutramine—obesity	0.000194	0.00187	CcSEcCtD
Cefazolin—Stevens-Johnson syndrome—Topiramate—obesity	0.000192	0.00185	CcSEcCtD
Cefazolin—Shock—Bupropion—obesity	0.000191	0.00184	CcSEcCtD
Cefazolin—Renal failure—Topiramate—obesity	0.000191	0.00184	CcSEcCtD
Cefazolin—Pain—Sibutramine—obesity	0.000191	0.00183	CcSEcCtD
Cefazolin—Thrombocytopenia—Bupropion—obesity	0.00019	0.00183	CcSEcCtD
Cefazolin—Feeling abnormal—Orlistat—obesity	0.00019	0.00183	CcSEcCtD
Cefazolin—Stomatitis—Topiramate—obesity	0.000189	0.00182	CcSEcCtD
Cefazolin—Cefpiramide—ALB—obesity	0.000189	0.108	CrCbGaD
Cefazolin—Gastrointestinal pain—Orlistat—obesity	0.000188	0.00181	CcSEcCtD
Cefazolin—Anorexia—Bupropion—obesity	0.000185	0.00178	CcSEcCtD
Cefazolin—Feeling abnormal—Sibutramine—obesity	0.000184	0.00177	CcSEcCtD
Cefazolin—Urticaria—Orlistat—obesity	0.000183	0.00176	CcSEcCtD
Cefazolin—Gastrointestinal pain—Sibutramine—obesity	0.000182	0.00175	CcSEcCtD
Cefazolin—Body temperature increased—Orlistat—obesity	0.000182	0.00175	CcSEcCtD
Cefazolin—Abdominal pain—Orlistat—obesity	0.000182	0.00175	CcSEcCtD
Cefazolin—Hypotension—Bupropion—obesity	0.000182	0.00175	CcSEcCtD
Cefazolin—Agranulocytosis—Topiramate—obesity	0.000181	0.00174	CcSEcCtD
Cefazolin—Urticaria—Sibutramine—obesity	0.000177	0.0017	CcSEcCtD
Cefazolin—Body temperature increased—Sibutramine—obesity	0.000176	0.0017	CcSEcCtD
Cefazolin—Abdominal pain—Sibutramine—obesity	0.000176	0.0017	CcSEcCtD
Cefazolin—Haemoglobin—Topiramate—obesity	0.000175	0.00169	CcSEcCtD
Cefazolin—Haemorrhage—Topiramate—obesity	0.000174	0.00168	CcSEcCtD
Cefazolin—Hepatitis—Topiramate—obesity	0.000174	0.00168	CcSEcCtD
Cefazolin—Somnolence—Bupropion—obesity	0.000173	0.00166	CcSEcCtD
Cefazolin—Dyspepsia—Bupropion—obesity	0.000171	0.00165	CcSEcCtD
Cefazolin—Hypersensitivity—Orlistat—obesity	0.00017	0.00163	CcSEcCtD
Cefazolin—Decreased appetite—Bupropion—obesity	0.000169	0.00163	CcSEcCtD
Cefazolin—Fatigue—Bupropion—obesity	0.000168	0.00161	CcSEcCtD
Cefazolin—Pain—Bupropion—obesity	0.000166	0.0016	CcSEcCtD
Cefazolin—Asthenia—Orlistat—obesity	0.000165	0.00159	CcSEcCtD
Cefazolin—Erythema multiforme—Topiramate—obesity	0.000165	0.00159	CcSEcCtD
Cefazolin—Cefonicid—ALB—obesity	0.000165	0.0937	CrCbGaD
Cefazolin—Hypersensitivity—Sibutramine—obesity	0.000164	0.00158	CcSEcCtD
Cefazolin—Pruritus—Orlistat—obesity	0.000163	0.00157	CcSEcCtD
Cefazolin—Feeling abnormal—Bupropion—obesity	0.00016	0.00154	CcSEcCtD
Cefazolin—Asthenia—Sibutramine—obesity	0.00016	0.00154	CcSEcCtD
Cefazolin—Gastrointestinal pain—Bupropion—obesity	0.000159	0.00153	CcSEcCtD
Cefazolin—Pruritus—Sibutramine—obesity	0.000158	0.00152	CcSEcCtD
Cefazolin—Diarrhoea—Orlistat—obesity	0.000158	0.00152	CcSEcCtD
Cefazolin—Urticaria—Bupropion—obesity	0.000154	0.00149	CcSEcCtD
Cefazolin—Abdominal pain—Bupropion—obesity	0.000154	0.00148	CcSEcCtD
Cefazolin—Body temperature increased—Bupropion—obesity	0.000154	0.00148	CcSEcCtD
Cefazolin—Diarrhoea—Sibutramine—obesity	0.000153	0.00147	CcSEcCtD
Cefazolin—Dizziness—Orlistat—obesity	0.000152	0.00147	CcSEcCtD
Cefazolin—Flatulence—Topiramate—obesity	0.000149	0.00144	CcSEcCtD
Cefazolin—Dizziness—Sibutramine—obesity	0.000147	0.00142	CcSEcCtD
Cefazolin—Vomiting—Orlistat—obesity	0.000146	0.00141	CcSEcCtD
Cefazolin—Rash—Orlistat—obesity	0.000145	0.0014	CcSEcCtD
Cefazolin—Dermatitis—Orlistat—obesity	0.000145	0.0014	CcSEcCtD
Cefazolin—Cefmetazole—ALB—obesity	0.000145	0.0825	CrCbGaD
Cefazolin—Headache—Orlistat—obesity	0.000144	0.00139	CcSEcCtD
Cefazolin—Hypersensitivity—Bupropion—obesity	0.000143	0.00138	CcSEcCtD
Cefazolin—Vomiting—Sibutramine—obesity	0.000142	0.00136	CcSEcCtD
Cefazolin—Rash—Sibutramine—obesity	0.000141	0.00135	CcSEcCtD
Cefazolin—Dermatitis—Sibutramine—obesity	0.00014	0.00135	CcSEcCtD
Cefazolin—Anaemia—Topiramate—obesity	0.00014	0.00135	CcSEcCtD
Cefazolin—Headache—Sibutramine—obesity	0.00014	0.00134	CcSEcCtD
Cefazolin—Asthenia—Bupropion—obesity	0.000139	0.00134	CcSEcCtD
Cefazolin—Agitation—Topiramate—obesity	0.000139	0.00134	CcSEcCtD
Cefazolin—Pruritus—Bupropion—obesity	0.000137	0.00132	CcSEcCtD
Cefazolin—Nausea—Orlistat—obesity	0.000137	0.00132	CcSEcCtD
Cefazolin—Syncope—Topiramate—obesity	0.000136	0.00131	CcSEcCtD
Cefazolin—Leukopenia—Topiramate—obesity	0.000136	0.00131	CcSEcCtD
Cefazolin—Loss of consciousness—Topiramate—obesity	0.000133	0.00128	CcSEcCtD
Cefazolin—Diarrhoea—Bupropion—obesity	0.000133	0.00128	CcSEcCtD
Cefazolin—Nausea—Sibutramine—obesity	0.000132	0.00127	CcSEcCtD
Cefazolin—Convulsion—Topiramate—obesity	0.000131	0.00127	CcSEcCtD
Cefazolin—Dizziness—Bupropion—obesity	0.000129	0.00124	CcSEcCtD
Cefazolin—Confusional state—Topiramate—obesity	0.000125	0.0012	CcSEcCtD
Cefazolin—Vomiting—Bupropion—obesity	0.000124	0.00119	CcSEcCtD
Cefazolin—Rash—Bupropion—obesity	0.000123	0.00118	CcSEcCtD
Cefazolin—Dermatitis—Bupropion—obesity	0.000122	0.00118	CcSEcCtD
Cefazolin—Shock—Topiramate—obesity	0.000122	0.00117	CcSEcCtD
Cefazolin—Headache—Bupropion—obesity	0.000122	0.00117	CcSEcCtD
Cefazolin—Thrombocytopenia—Topiramate—obesity	0.000121	0.00117	CcSEcCtD
Cefazolin—Anorexia—Topiramate—obesity	0.000118	0.00114	CcSEcCtD
Cefazolin—Hypotension—Topiramate—obesity	0.000116	0.00111	CcSEcCtD
Cefazolin—Nausea—Bupropion—obesity	0.000115	0.00111	CcSEcCtD
Cefazolin—Somnolence—Topiramate—obesity	0.00011	0.00106	CcSEcCtD
Cefazolin—Dyspepsia—Topiramate—obesity	0.000109	0.00105	CcSEcCtD
Cefazolin—Decreased appetite—Topiramate—obesity	0.000108	0.00104	CcSEcCtD
Cefazolin—Fatigue—Topiramate—obesity	0.000107	0.00103	CcSEcCtD
Cefazolin—Pain—Topiramate—obesity	0.000106	0.00102	CcSEcCtD
Cefazolin—Feeling abnormal—Topiramate—obesity	0.000102	0.000982	CcSEcCtD
Cefazolin—Gastrointestinal pain—Topiramate—obesity	0.000101	0.000975	CcSEcCtD
Cefazolin—Urticaria—Topiramate—obesity	9.84e-05	0.000947	CcSEcCtD
Cefazolin—Body temperature increased—Topiramate—obesity	9.79e-05	0.000942	CcSEcCtD
Cefazolin—Abdominal pain—Topiramate—obesity	9.79e-05	0.000942	CcSEcCtD
Cefazolin—Cefoperazone—ALB—obesity	9.7e-05	0.0552	CrCbGaD
Cefazolin—Hypersensitivity—Topiramate—obesity	9.12e-05	0.000878	CcSEcCtD
Cefazolin—Asthenia—Topiramate—obesity	8.88e-05	0.000855	CcSEcCtD
Cefazolin—Pruritus—Topiramate—obesity	8.76e-05	0.000843	CcSEcCtD
Cefazolin—Diarrhoea—Topiramate—obesity	8.47e-05	0.000815	CcSEcCtD
Cefazolin—Dizziness—Topiramate—obesity	8.19e-05	0.000788	CcSEcCtD
Cefazolin—Vomiting—Topiramate—obesity	7.87e-05	0.000758	CcSEcCtD
Cefazolin—Rash—Topiramate—obesity	7.81e-05	0.000751	CcSEcCtD
Cefazolin—Dermatitis—Topiramate—obesity	7.8e-05	0.000751	CcSEcCtD
Cefazolin—Headache—Topiramate—obesity	7.76e-05	0.000747	CcSEcCtD
Cefazolin—Ceftriaxone—ALB—obesity	7.56e-05	0.043	CrCbGaD
Cefazolin—Nausea—Topiramate—obesity	7.35e-05	0.000708	CcSEcCtD
Cefazolin—Cefalotin—ALB—obesity	6.62e-05	0.0377	CrCbGaD
Cefazolin—Cephalexin—ALB—obesity	6.02e-05	0.0342	CrCbGaD
Cefazolin—ALB—Platelet degranulation—TGFB1—obesity	1.59e-05	0.000154	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—APOA5—obesity	1.58e-05	0.000153	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—PRKCD—obesity	1.57e-05	0.000152	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—GNAS—obesity	1.56e-05	0.000151	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—TGFB1—obesity	1.56e-05	0.000151	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—PPARA—obesity	1.55e-05	0.00015	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—F2—obesity	1.53e-05	0.000148	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—PRKCB—obesity	1.53e-05	0.000148	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—APOB—obesity	1.53e-05	0.000148	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PRKAR2B—obesity	1.53e-05	0.000148	CbGpPWpGaD
Cefazolin—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—obesity	1.52e-05	0.000147	CbGpPWpGaD
Cefazolin—SLC22A11—Transmembrane transport of small molecules—ALB—obesity	1.51e-05	0.000146	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—CLOCK—obesity	1.51e-05	0.000146	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ME1—obesity	1.5e-05	0.000145	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ALDH6A1—obesity	1.5e-05	0.000145	CbGpPWpGaD
Cefazolin—ALB—Metabolism—SUCLG2—obesity	1.5e-05	0.000145	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—PPARA—obesity	1.48e-05	0.000144	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PIK3CG—obesity	1.48e-05	0.000143	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—SULT2A1—obesity	1.47e-05	0.000142	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—PIK3CG—obesity	1.47e-05	0.000142	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—APOA1—obesity	1.45e-05	0.00014	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—SLC22A1—obesity	1.43e-05	0.000139	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PPARG—obesity	1.43e-05	0.000138	CbGpPWpGaD
Cefazolin—ALB—Metabolism—COX7C—obesity	1.41e-05	0.000137	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PNPLA3—obesity	1.41e-05	0.000137	CbGpPWpGaD
Cefazolin—ALB—Metabolism—UCP1—obesity	1.41e-05	0.000137	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—APOA1—obesity	1.41e-05	0.000137	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—POMC—obesity	1.41e-05	0.000136	CbGpPWpGaD
Cefazolin—ALB—Folate Metabolism—IL6—obesity	1.4e-05	0.000136	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—INS—obesity	1.4e-05	0.000135	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—APOA1—obesity	1.39e-05	0.000135	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—TNF—obesity	1.38e-05	0.000133	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—TF—obesity	1.37e-05	0.000133	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—PRKCB—obesity	1.35e-05	0.00013	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—F2—obesity	1.35e-05	0.00013	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—CPT1A—obesity	1.34e-05	0.00013	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—IGF1—obesity	1.34e-05	0.00013	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—AKT2—obesity	1.34e-05	0.00013	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CS—obesity	1.34e-05	0.00013	CbGpPWpGaD
Cefazolin—ALB—Metabolism—DGAT2—obesity	1.34e-05	0.00013	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CPS1—obesity	1.34e-05	0.00013	CbGpPWpGaD
Cefazolin—ALB—Metabolism—SUCLA2—obesity	1.34e-05	0.00013	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—obesity	1.33e-05	0.000129	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—PRKAR2B—obesity	1.32e-05	0.000128	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—LIPC—obesity	1.31e-05	0.000127	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—APOC3—obesity	1.3e-05	0.000126	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PIK3CD—obesity	1.3e-05	0.000126	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—PPARA—obesity	1.29e-05	0.000125	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—PIK3CD—obesity	1.29e-05	0.000125	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—PIK3CG—obesity	1.29e-05	0.000125	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—ALB—obesity	1.28e-05	0.000124	CbGpPWpGaD
Cefazolin—ALB—Metabolism—LIPE—obesity	1.28e-05	0.000124	CbGpPWpGaD
Cefazolin—ALB—Metabolism—MUT—obesity	1.28e-05	0.000124	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—SERPINE1—obesity	1.28e-05	0.000123	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—ALB—obesity	1.27e-05	0.000123	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—CETP—obesity	1.26e-05	0.000122	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—SDC1—obesity	1.25e-05	0.000121	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—GCK—obesity	1.25e-05	0.000121	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—RHOA—obesity	1.23e-05	0.000119	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—AKR1C3—obesity	1.23e-05	0.000119	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PIK3R1—obesity	1.23e-05	0.000119	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—NOS3—obesity	1.23e-05	0.000119	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CYB5A—obesity	1.23e-05	0.000119	CbGpPWpGaD
Cefazolin—ALB—Metabolism—DGAT1—obesity	1.23e-05	0.000119	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—PIK3R1—obesity	1.22e-05	0.000118	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—NOS3—obesity	1.22e-05	0.000118	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—APOA1—obesity	1.21e-05	0.000117	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—SCARB1—obesity	1.21e-05	0.000117	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—CETP—obesity	1.2e-05	0.000116	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—TF—obesity	1.19e-05	0.000115	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ACLY—obesity	1.18e-05	0.000114	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—IGF1—obesity	1.18e-05	0.000114	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—AKT2—obesity	1.18e-05	0.000114	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—SREBF1—obesity	1.18e-05	0.000114	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—NOS1—obesity	1.15e-05	0.000111	CbGpPWpGaD
Cefazolin—SLC22A8—Transmembrane transport of small molecules—ALB—obesity	1.15e-05	0.000111	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ENPP1—obesity	1.14e-05	0.00011	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ALOX12—obesity	1.14e-05	0.00011	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—TFRC—obesity	1.14e-05	0.00011	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—PIK3CD—obesity	1.13e-05	0.00011	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PIK3CB—obesity	1.13e-05	0.00011	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—PIK3CB—obesity	1.12e-05	0.000109	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PTGS2—obesity	1.12e-05	0.000109	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—SERPINE1—obesity	1.12e-05	0.000108	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PTPN1—obesity	1.12e-05	0.000108	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—FASN—obesity	1.12e-05	0.000108	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—BCHE—obesity	1.11e-05	0.000108	CbGpPWpGaD
Cefazolin—ALB—Selenium Micronutrient Network—IL6—obesity	1.11e-05	0.000108	CbGpPWpGaD
Cefazolin—ALB—Metabolism—HMGCS1—obesity	1.1e-05	0.000107	CbGpPWpGaD
Cefazolin—ABCC4—Transmembrane transport of small molecules—ALB—obesity	1.1e-05	0.000107	CbGpPWpGaD
Cefazolin—ABCC4—Platelet activation, signaling and aggregation—AKT1—obesity	1.09e-05	0.000105	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—RHOA—obesity	1.08e-05	0.000105	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ACADM—obesity	1.07e-05	0.000104	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PLIN1—obesity	1.07e-05	0.000104	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PFKFB3—obesity	1.07e-05	0.000104	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PNPLA2—obesity	1.07e-05	0.000104	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ANGPTL4—obesity	1.07e-05	0.000104	CbGpPWpGaD
Cefazolin—ALB—Metabolism—SAT1—obesity	1.07e-05	0.000104	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—PIK3R1—obesity	1.07e-05	0.000103	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CYTB—obesity	1.04e-05	0.000101	CbGpPWpGaD
Cefazolin—ALB—Metabolism—OXCT1—obesity	1.04e-05	0.000101	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ACACB—obesity	1.04e-05	0.000101	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PLG—obesity	1.04e-05	0.000101	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PNLIP—obesity	1.02e-05	9.83e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—SRD5A1—obesity	1.02e-05	9.83e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—SDC3—obesity	9.92e-06	9.59e-05	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—PIK3CB—obesity	9.88e-06	9.55e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—GGT1—obesity	9.87e-06	9.55e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—NCOA1—obesity	9.72e-06	9.4e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—STS—obesity	9.69e-06	9.38e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CYP26B1—obesity	9.69e-06	9.38e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—HK2—obesity	9.69e-06	9.38e-05	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—SLC2A4—obesity	9.69e-06	9.37e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—GNB3—obesity	9.65e-06	9.33e-05	CbGpPWpGaD
Cefazolin—SLC22A6—Transmembrane transport of small molecules—ALB—obesity	9.6e-06	9.29e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—CYP19A1—obesity	9.58e-06	9.27e-05	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—CYCS—obesity	9.56e-06	9.25e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PPARD—obesity	9.48e-06	9.17e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—IGF2—obesity	9.47e-06	9.16e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—GNAS—obesity	9.39e-06	9.09e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—SLC27A1—obesity	9.29e-06	8.99e-05	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—NCOA1—obesity	9.24e-06	8.94e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—APOB—obesity	9.2e-06	8.9e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GLUL—obesity	9.11e-06	8.81e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—FABP4—obesity	9.11e-06	8.81e-05	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—PLG—obesity	9.01e-06	8.71e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PPARGC1A—obesity	8.78e-06	8.5e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—UCP3—obesity	8.64e-06	8.36e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—HSD11B1—obesity	8.64e-06	8.36e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—UCP2—obesity	8.64e-06	8.36e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ECHS1—obesity	8.64e-06	8.36e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ADH1B—obesity	8.5e-06	8.22e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—APOB—obesity	8.37e-06	8.1e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ACSL1—obesity	8.37e-06	8.09e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PPARGC1B—obesity	8.37e-06	8.09e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GPAM—obesity	8.37e-06	8.09e-05	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—GNB3—obesity	8.35e-06	8.08e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—CD36—obesity	8.34e-06	8.07e-05	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—HMOX1—obesity	8.31e-06	8.04e-05	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—GNAS—obesity	8.13e-06	7.86e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PCK1—obesity	8.12e-06	7.86e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—FADS1—obesity	8.12e-06	7.86e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—HADH—obesity	8.12e-06	7.86e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PRKCD—obesity	8.09e-06	7.83e-05	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—TGFB1—obesity	8.06e-06	7.8e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—LPL—obesity	8e-06	7.73e-05	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—APOB—obesity	7.96e-06	7.7e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—ACP5—obesity	7.9e-06	7.64e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—GPX1—obesity	7.8e-06	7.55e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—G6PD—obesity	7.7e-06	7.45e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—SREBF2—obesity	7.6e-06	7.36e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—HK1—obesity	7.6e-06	7.36e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—CD36—obesity	7.6e-06	7.35e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—LPA—obesity	7.34e-06	7.11e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—CAV1—obesity	7.29e-06	7.06e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—APOA1—obesity	7.28e-06	7.04e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—LPIN1—obesity	7.19e-06	6.95e-05	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—TGFB1—obesity	7.07e-06	6.84e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PPARA—obesity	7.06e-06	6.83e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—APOA5—obesity	7.04e-06	6.81e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—F2—obesity	6.94e-06	6.72e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PRKCB—obesity	6.94e-06	6.72e-05	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—PIK3CA—obesity	6.91e-06	6.68e-05	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—PIK3CA—obesity	6.86e-06	6.63e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—AGT—obesity	6.84e-06	6.62e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—SLC22A1—obesity	6.72e-06	6.5e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CLOCK—obesity	6.72e-06	6.5e-05	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—PPARA—obesity	6.72e-06	6.5e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—APOE—obesity	6.7e-06	6.48e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PIK3CG—obesity	6.64e-06	6.43e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—CAV1—obesity	6.64e-06	6.42e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—APOA1—obesity	6.62e-06	6.41e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—SULT2A1—obesity	6.55e-06	6.33e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GLP1R—obesity	6.55e-06	6.33e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—DPYD—obesity	6.44e-06	6.23e-05	CbGpPWpGaD
Cefazolin—ALB—Transmembrane transport of small molecules—APOA1—obesity	6.3e-06	6.09e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PRKAR2B—obesity	6.2e-06	6e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—DCN—obesity	6.15e-06	5.95e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—IGF1—obesity	6.08e-06	5.88e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—AKT2—obesity	6.08e-06	5.88e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PIK3CG—obesity	6.05e-06	5.85e-05	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—PIK3CA—obesity	6.02e-06	5.82e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CPT1A—obesity	5.99e-06	5.79e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—NAMPT—obesity	5.87e-06	5.68e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PIK3CD—obesity	5.84e-06	5.65e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PPARG—obesity	5.84e-06	5.65e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GCK—obesity	5.83e-06	5.64e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—LIPC—obesity	5.83e-06	5.64e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—APOC3—obesity	5.8e-06	5.61e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—SERPINE1—obesity	5.78e-06	5.59e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—POMC—obesity	5.76e-06	5.57e-05	CbGpPWpGaD
Cefazolin—TPMT—Metabolism—AKT1—obesity	5.64e-06	5.46e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CETP—obesity	5.63e-06	5.45e-05	CbGpPWpGaD
Cefazolin—ABCC4—Hemostasis—AKT1—obesity	5.6e-06	5.42e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—RHOA—obesity	5.57e-06	5.39e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—SDC1—obesity	5.57e-06	5.38e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PIK3R1—obesity	5.51e-06	5.33e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—NOS3—obesity	5.51e-06	5.33e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—AKR1C3—obesity	5.48e-06	5.3e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—SCARB1—obesity	5.39e-06	5.21e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PIK3CD—obesity	5.32e-06	5.14e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—SREBF1—obesity	5.23e-06	5.06e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GOT2—obesity	5.09e-06	4.92e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PIK3CB—obesity	5.09e-06	4.92e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PIK3R1—obesity	5.02e-06	4.86e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—FASN—obesity	4.98e-06	4.82e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—BCHE—obesity	4.96e-06	4.8e-05	CbGpPWpGaD
Cefazolin—ALB—Platelet activation, signaling and aggregation—AKT1—obesity	4.92e-06	4.76e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CYP2E1—obesity	4.79e-06	4.63e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—NQO1—obesity	4.73e-06	4.58e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PIK3CB—obesity	4.63e-06	4.48e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PTGS2—obesity	4.59e-06	4.44e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—SLC2A4—obesity	4.54e-06	4.39e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GCG—obesity	4.54e-06	4.39e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CYCS—obesity	4.48e-06	4.33e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GGT1—obesity	4.39e-06	4.25e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GOT1—obesity	4.39e-06	4.25e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—NCOA1—obesity	4.33e-06	4.19e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CYP19A1—obesity	4.27e-06	4.13e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—STK11—obesity	4.27e-06	4.13e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—COMT—obesity	3.97e-06	3.84e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PPARGC1A—obesity	3.91e-06	3.78e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GNB3—obesity	3.91e-06	3.78e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—HMOX1—obesity	3.89e-06	3.77e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GNAS—obesity	3.81e-06	3.68e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—APOB—obesity	3.73e-06	3.61e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—TGFB1—obesity	3.65e-06	3.53e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—LPL—obesity	3.56e-06	3.44e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—GPX1—obesity	3.47e-06	3.36e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CD36—obesity	3.38e-06	3.27e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—MTHFR—obesity	3.21e-06	3.1e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PPARA—obesity	3.15e-06	3.04e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—PIK3CA—obesity	3.1e-06	3e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—AGT—obesity	3.05e-06	2.95e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—APOE—obesity	2.98e-06	2.89e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—CAV1—obesity	2.96e-06	2.86e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—APOA1—obesity	2.95e-06	2.85e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—obesity	2.83e-06	2.73e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PIK3CG—obesity	2.69e-06	2.61e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PPARG—obesity	2.6e-06	2.51e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—POMC—obesity	2.56e-06	2.48e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—INS—obesity	2.55e-06	2.47e-05	CbGpPWpGaD
Cefazolin—ALB—Hemostasis—AKT1—obesity	2.54e-06	2.45e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PIK3CD—obesity	2.37e-06	2.29e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—NOS3—obesity	2.24e-06	2.16e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PIK3R1—obesity	2.24e-06	2.16e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PIK3CB—obesity	2.06e-06	2e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PTGS2—obesity	2.05e-06	1.98e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—PIK3CA—obesity	1.26e-06	1.22e-05	CbGpPWpGaD
Cefazolin—ALB—Metabolism—AKT1—obesity	1.03e-06	9.94e-06	CbGpPWpGaD
